摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-3-(2-nitropropan-2-yl)cyclohexanone | 4908-50-3

中文名称
——
中文别名
——
英文名称
(+/-)-3-(2-nitropropan-2-yl)cyclohexanone
英文别名
3-(2-nitropropan-2-yl)cyclohexanone;3-(1-methyl-1-nitroethyl)cyclohexanone;3-(2-nitropropan-2-yl)cyclohexan-1-one
(+/-)-3-(2-nitropropan-2-yl)cyclohexanone化学式
CAS
4908-50-3
化学式
C9H15NO3
mdl
——
分子量
185.223
InChiKey
AQRSKQXZONHAFO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    102-107 °C
  • 密度:
    1.1353 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (+/-)-3-(2-nitropropan-2-yl)cyclohexanone 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 生成 3-(1-Methyl-1-nitro-ethyl)-cyclohexanol
    参考文献:
    名称:
    Lipase-mediated diastereoselective and enantioselective acetylations of 3-substituted cyclohexanols
    摘要:
    Lipase-mediated acetylation of four diastereomeric and enatiomeric isomers of 3-substituted cyclohexanols 2 has led to an efficient resolution to provide a single stereoisomer, (1R,3S)-cyclohexyl acetate (1R,3S)-3 in a high enantiomeric excess. (C) 1998 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(97)10705-5
  • 作为产物:
    描述:
    硝基乙烷2-环己烯-1-酮 在 Merrifield resin-bound azidoproazaphosphatrane 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以94%的产率得到(+/-)-3-(2-nitropropan-2-yl)cyclohexanone
    参考文献:
    名称:
    Merrifield Resin-C 6 H 4 CH 2 N 3 P(MeNCH 2 CH 2)3 N:一种高效的可重复使用的室温室温1,4-加成反应催化剂,及其前体P(MeNCH 2 CH 2)的合成更加方便3 N
    摘要:
    室温下,标题为可重复使用的Merrifield树脂负载的催化剂可有效地催化1,4-加成物中具有多种供体的多种Michael受体。该催化剂的优点包括简单的后处理(反应混合物的过滤)和良好至极好的产物产率。我们还报告了商业上可获得的强非离子碱1的大幅简化合成,该碱是标题聚合物结合的催化剂的前体。
    DOI:
    10.1021/jo062505z
点击查看最新优质反应信息

文献信息

  • Solvent-Free Henry and Michael Reactions with Nitroalkanes Promoted by Potassium Carbonate as a Versatile Heterogeneous Catalyst
    作者:Giovanna Bosica、Kurt Polidano
    DOI:10.1155/2017/6267036
    日期:——
    The use of a simple weak inorganic base such as potassium carbonate facilitated the formation of carbon-carbon bonds through both the Henry and the Michael reactions with nitrocompounds. The application of this catalyst under environmentally friendly solventless heterogeneous conditions gave satisfactory to good yields of β-nitroalcohols, involving aliphatic and aromatic starting materials, as well
    使用简单的弱无机碱(例如碳酸钾)通过与硝基化合物的亨利和迈克尔反应促进了碳-碳键的形成。该催化剂在环境友好的无溶剂多相条件下的应用使β-硝基醇的产率令人满意,涉及脂肪族和芳香族起始原料,以及使用几种不同的迈克尔受体和硝基烷烃形成迈克尔加合物的产率很高。
  • Functionalized Chiral Ionic Liquid Catalyzed Asymmetric SN1 α-Alkylation of Ketones and Aldehydes
    作者:Long Zhang、Lingyun Cui、Xin Li、Jiuyuan Li、Sanzhong Luo、Jin-Pei Cheng
    DOI:10.1002/ejoc.201000609
    日期:2010.9
    Pyrrolidine-derived functionalized chiral ionic liquids (FCILs) have been found to catalyze asymmetric S N 1 α-alkylations of ketones and aldehydes with up to 99 % yield, >99:1 dr and 87 % ee. The FCIL catalysts enable S N 1 α-alkylations of cyclic ketones, particularly of 3- and 4-substituted cyclohexanones with excellent diastereoselectivity and good enantioselectivity, featuring unprecedented desymmetrization
    已发现吡咯烷衍生的官能化手性离子液体 (FCIL) 可催化酮和醛的不对称 SN 1 α-烷基化反应,产率高达 99%,>99:1 dr 和 87% ee。FCIL 催化剂使环酮,特别是 3-和 4-取代环己酮的 SN 1 α-烷基化具有优异的非对映选择性和良好的对映选择性,为这些类型的不对称反应提供了前所未有的去对称化和动力学拆分过程。介绍了这项研究的全部细节以及提议的烯胺过渡态。
  • Rho kinase inhibitors
    申请人:——
    公开号:US20040138286A1
    公开(公告)日:2004-07-15
    A compound represented by the formula (1): 1 wherein R 1 —X— indicates that 1 to 4 R 1 —X— groups are present which may be the same or different, the ring A is a saturated or unsaturated 5-membered heterocyclic ring, X is a single bond, a group represented by the formula: —N(R 3 )—, —O— or —S—, or the like. R 1 is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, R 2 is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, and R 3 is a hydrogen atom, a substituted or unsubstituted alkyl group, or the like; a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug is a useful compound as a therapeutic agent for diseases for which Rho kinase is responsible.
    化合物的化学式为(1):1,其中R1—X—表示存在1到4个R1—X—基团,可以相同也可以不同,环A是饱和或不饱和的5元杂环,X是单键,一个由式子表示的基团:—N(R3)—,—O—或—S—等。R1是氢原子,卤素原子,硝基,羧基,取代或未取代的烷基或类似物,R2是氢原子,卤素原子,硝基,羧基,取代或未取代的烷基或类似物,R3是氢原子,取代或未取代的烷基或类似物;该化合物的前药或药物可接受的盐是治疗Rho激酶相关疾病的有用化合物。
  • Rho KINASE INHIBITORS
    申请人:Sumitomo Pharmaceuticals Company, Limited
    公开号:EP1403255A1
    公开(公告)日:2004-03-31
    A compound represented by the formula (1): wherein R1-X- indicates that 1 to 4 R1-X- groups are present which may be the same or different,    the ring A is a saturated or unsaturated 5-membered heterocyclic ring,    X is a single bond, a group represented by the formula: -N(R3)-, -O- or -S-, or the like.    R1 is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like,    R2 is a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, and    R3 is a hydrogen atom, a substituted or unsubstituted alkyl group, or the like; a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug is a useful compound as a therapeutic agent for diseases for which Rho kinase is responsible.
    由式(1)代表的化合物: 其中 R1-X- 表示存在 1 至 4 个 R1-X- 基团,这些基团可以相同或不同、 环 A 是饱和或不饱和的五元杂环、 X 是单键、由式子表示的基团:-N(R3)-、-O- 或 -S- 或类似的基团。 R1 是氢原子、卤素原子、硝基、羧基、取代或未取代的烷基或类似基团、 R2 是氢原子、卤素原子、硝基、羧基、取代或未取代的烷基或类似物,以及 R3 是氢原子、取代或未取代的烷基或类似物; 所述化合物的原药或所述化合物或原药的药学上可接受的盐是一种有用的化合物,可作为治疗 Rho 激酶引起的疾病的药物。
  • Proline derivatives supported on polymers through triazole or tetrazole linkers for organocatalytic applications
    申请人:Institut Catala D'Investigacio Quimica
    公开号:EP1892042A1
    公开(公告)日:2008-02-27
    The present invention relates to novel organocatalysts for carrying out asymmetric reactions, which are proline derivatives supported on polymers. through triazole or tetrazole linkers. The organocatalysts show a high purity and a high stereoselectivity, and excellent results has been obtained not only with organic solvents but also with water as solvent.
    本发明涉及用于进行不对称反应的新型有机催化剂,这些催化剂是通过三唑或四 唑连接体支撑在聚合物上的脯氨酸衍生物。这种有机催化剂具有高纯度和高立体选择性,不仅在使用有机溶剂时,而且在使用水作为溶剂时,都能获得极佳的效果。
查看更多